The powerful cardioprotective effects of urocortin and the corticotropin releasing hormone (CRH) family

被引:41
作者
Davidson, Sean M. [1 ,2 ]
Rybka, Aneta E. [3 ]
Townsend, Paul A. [3 ]
机构
[1] Univ Coll London Hosp, Hatter Cardiovasc Inst, London WC1E 6HX, England
[2] Sch Med, London WC1E 6HX, England
[3] Univ Southampton, Southampton Gen Hosp, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England
基金
英国医学研究理事会; 英国生物技术与生命科学研究理事会;
关键词
Urocortin; Cardiovascular; Cardioprotection; Heart failure; Ischemia and reperfusion; MITOCHONDRIAL PERMEABILITY TRANSITION; ISCHEMIA-REPERFUSION INJURY; PROTEIN-KINASE-C; CARDIAC MYOCYTES; SKELETAL-MUSCLE; TUMOR-GROWTH; HUMAN HEART; EXPRESSION; PEPTIDES; PATHWAYS;
D O I
10.1016/j.bcp.2008.08.033
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The urocortins are members of the corticotropin releasing hormone (CRH) family of peptide hormones. The archetypal member of this family, CRH, plays an important role in regulating thermogenesis and homeostasis by acting centrally and systemically in target organs via its two receptors CRH-R1 and CRH-R2. However, by virtue of their much greater relative affinity for CRH-R2, the physiological effects of the urocortin peptides are largely restricted to peripheral organs such as the heart. A powerful cytoprotective effect of urocortin peptide administration against ischemia and reperfusion injury has been demonstrated in isolated cardiomyocyte models, as well as in the intact heart both in vitro and in vivo. Extremely promising data has shown the beneficial effect of treating pacing-induced heart failure in sheep with urocortin molecules. Though the efficacy and specificity of these molecules in humans is not yet established, molecular dissection of the cytoprotective pathways activated by urocortin peptides suggests that the beneficial effects may be separable from potentially deleterious effects. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 90 条
[31]   Urocortin2 inhibits tumor growth via effects on vascularization and cell proliferation [J].
Hao, Zhengrong ;
Huang, Yan ;
Cleman, Jake ;
Jovin, Ion S. ;
Vale, Wylie W. ;
Bale, Tracy L. ;
Giordano, Frank J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (10) :3939-3944
[32]   Survival kinases in ischemic preconditioning and postconditioning [J].
Hausenloy, Derek J. ;
Yellon, Derek M. .
CARDIOVASCULAR RESEARCH, 2006, 70 (02) :240-253
[33]   New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway [J].
Hausenloy, DJ ;
Yellon, DM .
CARDIOVASCULAR RESEARCH, 2004, 61 (03) :448-460
[34]   Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor [J].
Hsu, SY ;
Hsueh, AJW .
NATURE MEDICINE, 2001, 7 (05) :605-611
[35]   CLONING AND FUNCTIONAL-CHARACTERIZATION OF A NOVEL ATP-SENSITIVE POTASSIUM CHANNEL UBIQUITOUSLY EXPRESSED IN RAT-TISSUES, INCLUDING PANCREATIC-ISLETS, PITUITARY, SKELETAL-MUSCLE, AND HEART [J].
INAGAKI, N ;
TSUURA, Y ;
NAMBA, N ;
MASUDA, K ;
GONOI, T ;
HORIE, M ;
SEINO, Y ;
MIZUTA, M ;
SEINO, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (11) :5691-5694
[36]   The Cardioprotective Agent Urocortin Induces Expression of CT-1 [J].
Sadia Janjua ;
Kevin M. Lawrence ;
Leong L. Ng ;
David S. Latchman .
Cardiovascular Toxicology, 2003, 3 (3) :255-261
[37]   Central administration of urocortin inhibits vasopressin release in conscious rats [J].
Kakiya, S ;
Yokoi, H ;
Arima, H ;
Iwasaki, Y ;
Oki, Y ;
Oiso, Y .
NEUROSCIENCE LETTERS, 1998, 248 (02) :144-146
[38]   Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart [J].
Kimura, Y ;
Takahashi, K ;
Totsune, K ;
Muramatsu, Y ;
Kaneko, C ;
Darnel, AD ;
Suzuki, T ;
Ebina, M ;
Nukiwa, T ;
Sasano, H .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :340-346
[39]   RETRACTED: Cardiac release of urocortin precedes the occurrence of irreversible myocardial damage in the rat heart exposed to ischemia/reperfusion injury (Retracted article. See vol. 592, pg. 657, 2018) [J].
Knight, Richard A. ;
Chen-Scarabelli, Carol ;
Yuan, Zhaokan ;
McCauley, Roy B. ;
Di Rezze, J. ;
Scarabelli, Gabriele M. ;
Townsend, Paul A. ;
Latchman, David ;
Saravolatz, Louis ;
Faggian, Giuseppe ;
Mazzueco, Alessandro ;
Chowdrey, Hardial S. ;
Stephanou, Anastasis ;
Scarabelli, Tiziano M. .
FEBS LETTERS, 2008, 582 (06) :984-990
[40]   Urocortin protects against ischemic injury via a MAPK-dependent pathway [J].
Latchman, DS .
TRENDS IN CARDIOVASCULAR MEDICINE, 2001, 11 (05) :167-169